<?xml version="1.0" encoding="UTF-8"?>
<p>The potential for a herbal compound to negatively interact with conventional cancer treatments is considered a major concern among many oncologists, pharmacists, and other oncology healthcare professionals. It is also an important question for patients and, as the case vignette indicates, may impact their decision as to whether they should start or continue taking the herbal product at all. Many of these patients are interested in receiving guidance on the effective and safe use of herbal medicine, especially those undergoing active anticancer treatment. In a study of 76 oncology patients undergoing chemotherapy, 78% were reportedly using a herbal vitamin supplement in conjunction with their conventional treatment regimen, with 27% identified as using supplements with potential interactions with a negative impact on the conventional treatment. The overwhelming majority of patients using herbal products (&gt;85%) stated that they would discontinue their use or at least consult with their oncologist if they were to become aware of a potential for a harmful interaction with their conventional chemotherapy regimen [
 <xref rid="B34-pharmaceuticals-13-00455" ref-type="bibr">34</xref>].
</p>
